BIO KEY INTERNATIONAL INC
For the period ended Dec 31, 2023. Filed Jun 5, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Jun 5, 2024
BKYI$2.39+0.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 16. Form 10-K Summary
None.
FINANCIAL STATEMENTS
The following financial statements of BIO-key International, Inc. are included herein at the indicated page numbers:
| Report of Independent Registered Public Accounting Firm (Bush and Associates CPA., PCAOB ID:6797) | 39 |
|---|---|
| Report of Independent Registered Public Accounting Firm (Marcum LLC., PCAOB ID:688) | 40 |
| Consolidated Balance Sheets as of December 31, 2023 and 2022 | 41 |
| Consolidated Statements of Operations and Comprehensive Loss—Years ended December 31, 2023 and 2022 | 42 |
| Consolidated Statements of Stockholders’ Equity —Years ended December 31, 2023 and 2022 | 43 |
| Consolidated Statements of Cash Flows—Years ended December 31, 2023 and 2022 | 44 |
| Supplementary Disclosures of Cash Flow Information—Years ended December 31, 2023 and 2022 | 45 |
| Notes to the Consolidated Financial Statements—December 31, 2023 and 2022 | 46 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.